Transarterial chemoembolization of hepatocellular carcinoma in patients with the most common comorbidities or previous oncologic malignancy in remission.

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Transarterial?chemoembolization?of hepatocellular carcinoma in patients with the most common comorbidities or previous?oncologic?malignancy?in remission.
Authors	STRAKA Matej ANDRAŠINA Tomáš HUSTÝ Jakub MATKULČÍK Peter KAZDA Tomáš ROHAN Tomáš
Year of publication	2023
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Purpose: To analyze whether previously diagnosed common comorbidity (diabetes mellitus, myocardial infarction, ischemic stroke, chronic obstructive pulmonary disease (COPD) or prior malignancy in complete remission (CR) are independent risk factors afecting survival of patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE). Conclusion: Patiens with HCC treated with TACE and a history of mentioned comorbidities or other malignant tumor in complete remission have non-inferior survival compared to patients without comorbidities.
Related projects:	Evaluation of Efficacy and Optimization of Radiological Imaging and Interventional Methods